Search for: "Hyman, Phelps & McNamara, P.C." Results 41 - 60 of 150
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
21 Jan 2011, 6:39 am by FDABlog HPM
  The program, titled “The Economics of Orphan Drugs – Why Successful Cures Bring Challenges for Patients and Payment,” will be posted on the internet here, and featues Peter Saltonstall, President & CEO of the National Organization for Rare Disorders, Frank Sasinowski, Chairman of the Board at NORD (and Hyman, Phelps & McNamara, P.C. [read post]
29 Dec 2010, 5:30 pm by FDABlog HPM
In his latest article appearing in FDLI Update, Hyman, Phelps & McNamara, P.C. [read post]
19 Jan 2012, 7:46 pm by FDABlog HPM
  On March 21, 2012 (12:30 - 2:00 PM ET), Hyman, Phelps & McNamara, P.C. will host a free webinar, titled “FDA Appeals - Improving Your Odds of Success; Trends, Expectations, Strategies. [read post]
17 Jun 2012, 5:17 am by FDABlog HPM
Hyman, Phelps & McNamara P.C. invites you to register for our webinar, “Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA's Nontraditional Investigative Tools,” which is scheduled to take place on Wednesday, June 20, 2012 from 12:30 - 2:00 p.m. [read post]
10 May 2012, 3:26 pm by FDABlog HPM
Hyman, Phelps & McNamara P.C. invites you to register for our webinar, “Garbage Runs, Fake Identities, and Surprise Home Visits: Strategies to Deal With FDA's Nontraditional Investigative Tools,” which is scheduled to take place on Wednesday, June 20, 2012 from 12:30 - 2:00 p.m. [read post]
8 Aug 2012, 4:22 pm by FDABlog HPM
Hyman, Phelps & McNamara, P.C. is pleased to announce that Anne Walsh will moderate a panel on “Trends and Priorities in Enforcement” at this year’s Food and Drug Law Institute’s (“FDLI”) Advertising and Promotion Conference. [read post]
15 Apr 2010, 11:42 am by FDABlog HPM
The March/April 2010 issue of FDLI Update contains an article by Hyman, Phelps & McNamara, P.C. [read post]